Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2025-12-24 @ 4:12 PM
NCT ID:
NCT02872766
Eligibility Criteria:
Inclusion Criteria:
* Provide written informed consent
* Willingness to follow all instructions and comply with schedule for follow up visits
* Having myopia with manifest refraction spherical equivalent of -1.00 to -2.50 D, with cylindrical component pl to -0.75 D
* Social security insurance or equivalent
Exclusion Criteria:
* sensitivity to the use of the test article(s)
* hypersensitivity to local anesthesics
* Corneal pachymetry that is \< 480 microns
* Eyes with keratoconus
* Eyes which are aphakic or with corneal intacs
* Previous ocular condition (other than refractive error) in the eye to be treated that may predispose the eye for future complications. For example: History of corneal disease (e.g., herpes simplex, recurrent erosion syndrome, corneal dystrophy, refractive keratotomy etc.), clinically significant corneal scarring in the crosslinking treatment zone
* Pregnancy or lactation
* Patients with a current condition that, in the investigator's opinion, would interfere with or prolong epithelial healing
* Taking Vitamin C (ascorbic acid) supplements within 1 week of the cross-linking treatment.
* Juridical protection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02872766
Study Brief:
Protocol Section:
NCT02872766